Showing 61 - 70 of 130,835
.S. drug pricing system: Current law also provides weak incentives for medical innovation across wide areas, including vaccines … innovation not only slow the growth of U.S. life expectancy but also exacerbate racial disparities in health outcomes.High drug … prices and slow pharmaceutical progress are two facets of the same problem: a system that fails to reward medical innovation …
Persistent link: https://www.econbiz.de/10014078244
Persistent link: https://www.econbiz.de/10013463131
Persistent link: https://www.econbiz.de/10013493053
Persistent link: https://www.econbiz.de/10014245487
Persistent link: https://www.econbiz.de/10003375369
Persistent link: https://www.econbiz.de/10011348630
Persistent link: https://www.econbiz.de/10010347241
Health authorities are constantly searching for new ways to stabilise health expenditures. To explore this issue, we compared the costs generated by different types of medical practice in French general medicine: i.e. conventional (CM-GP), homeopathic (Ho-GP), or mixed (Mx-GP). Data from a...
Persistent link: https://www.econbiz.de/10011471577
Persistent link: https://www.econbiz.de/10002012442
Innovative products form the foundation for the international success of electromedical technology in Germany. This is shown both in the strong sales achieved by the German medical technology segment compared with other industrial countries and the export share of more than 70%, which even...
Persistent link: https://www.econbiz.de/10013015990